EU ERA PerMed Personalized Medicine
Laufzeit: 01.01.2021 - 31.12.2024
imported
Kurzfassung
Personalised multimodal therapies for the treatment of
lung cancer
Laufzeit: 01.01.2021 - 31.12.2024
Personalised multimodal therapies for the treatment of
lung cancer